State Council overhauls drug pricing mechanism
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
Pharmaceutical companies will be able to charge more for innovative drugs. On April 14, the State Council released a framework to reform how drug prices are set across China's healthcare system. Some context: Between 2018 and 2022, government-led volume-based procurement (VBP) cut drug prices by mo...